Day One Biopharmaceuticals · 1 day ago
Director, Precision Medicine
Day One Biopharmaceuticals is focused on advancing first- or best-in-class medicines for childhood and adult diseases. They are seeking a scientific leader to develop and maintain precision medicine vision and strategy, providing expertise in clinical diagnostics across their portfolio of targeted therapeutics for cancer.
BiopharmaBiotechnologyHealth CarePharmaceutical
Responsibilities
Develop and maintain precision medicine vision and strategy through cross-functional partnership with Leadership of Clinical Development, Translational Research, Regulatory Sciences, Clinical Pharmacology, and Commercial, as well as other Day One functions
Design and implement hypothesis-driven strategies to deliver evidence of target engagement, mechanisms of action/resistance, patient selection/CDx strategies and other clinically-relevant biomarker endpoints to advance the Day One pipeline
Provide technical, clinical and regulatory expertise in assay development and diagnostics (NGS, IHC, Immunoassays along with emerging biomarker technologies and platforms) across diverse stakeholders comprising leadership in Research and Development, Commercial, Regulatory Sciences, Medical Affairs, and Patient Advocacy, including but not limited to, training, education, and representation on behalf of our Translational and Precision Medicine-related events
Effectively partner with Precision Medicine leaders to execute on the development of clinical biomarkers, assay development through companion diagnostics to maximize patient access to Day One drugs
Manage external diagnostic partners, CROs, academic collaborators, and vendors to ensure high-quality biomarker and CDx deliverables
Leadership expertise in developing and maintaining precision medicine screening strategies across clinical programs, leveraging your extensive experience in testing report interpretation
Author and review Precision Medicine related publications as well as appropriate sections in clinical study / regulatory documents (i.e. INDs, IBs, trial protocols/ops manuals, ICFs, IRB responses, HA Briefing Books, CSRs, etc.)
Work closely with Business Development and Precision Medicine leaders to support candidate asset acquisition assessments through clinical biomarker and CDx considerations
Develop and implement comprehensive clinical biomarker strategy across clinical programs
Lead the strategic planning and execution of CDx development, including assay selection, analytical validation strategies, clinical validation plans, and alignment with regulatory and commercial partners
Help Day One remain a leader in oncology drug development across all ages
Engaging, inspiring, and successfully communicating with employees of any level in the organization
Understanding and embracing one of our highest values: that the most precious asset is our team
Proactively contributing to company-building and process evolution as we grow
Qualification
Required
Bachelor's degree in biology, immunology, chemistry, pharmacology, biochemistry, or related discipline
10+ years' experience in commercial diagnostic testing and/or oncology drug discovery/development setting within the biopharmaceutical industry (biotech or large pharma)
A diverse background across assay, diagnostics, cancer biology, and drug development is required with relevant expertise in the interpretation of clinical molecular diagnostic testing reports
Understanding of clinical biomarkers and Companion Diagnostics development strategy and execution is strongly desired
Ability to interpret complex molecular and clinical datasets and translate insights into program strategy
Unwavering integrity and trustworthiness, embodying Day One's core values
Eloquent and passionate when talking about science and the potential to help patients
Keen scientific acumen and intellectual curiosity, good judgement, and the highest scientific integrity
Curious, creative with an ability to think outside of traditional drug development and corporate models
A team player and a mentor – someone who cares for their colleagues as people as well as contributors and collaborators, while delivering results
Inspires the confidence of others, and inspires others to fulfill their potential
The ability to elicit and synthesize information from a range of individuals and sources rapidly and clearly communicate findings across the organization
Preferred
PhD or MD/PhD in biology, immunology, chemistry, pharmacology, biochemistry, or related discipline
Pediatric oncology and/or rare disease experiences
Start-up/small biotech experience is strongly preferred or a clear desire to dive into working with a small team
Company
Day One Biopharmaceuticals
Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.
Funding
Current Stage
Public CompanyTotal Funding
$687.5MKey Investors
RA Capital Management
2024-07-30Post Ipo Equity· $175M
2023-06-06Post Ipo Equity· $150M
2022-06-14Post Ipo Equity· $172.5M
Recent News
2026-01-06
2026-01-06
2026-01-06
Company data provided by crunchbase